This post is not the latest immunisation update and therefore may contain information or advice that is out of date. Please see our most recent update here.
Australia has commenced rolling out COVID-19 booster shots to the population following new advice from Australian Technical Advisory Group on Immunisation (ATAGI). People who are aged 18 years and over will be offered a booster shot six months after receiving their second dose. Immunisation providers must check the Australian Immunisation Register (AIR) prior to administering any COVID-19 vaccines.
General practices who have stock and available bookings can commence providing boosters immediately. It is important that patients are aware the booster vaccination is not mandatory, however they are recommended to maintain immunity against COVID-19.
Boosters can be funded through the existing MBS items 93644, 93645, 93646, 93647, 93653, 93654, 93655 and 93656 are available to assess patients’ suitability for the second or subsequent dose of a COVID-19 vaccine dose.
From 1 November 2021, AstraZeneca COVISHIELD (ASTCOV), Sinopharm BBIBP-CorV (SINBBI), and Sinovac Coronavac (SINCOR) can now be recorded on the Australian Immunisation Register (AIR) if they were given on or after 1 October 2020. As with other COVID-19 vaccines administered overseas, records must include a Country of immunisation and a Batch Number to be recorded on the AIR.
A list of all vaccines currently able to be reported to AIR is available on the AIR vaccine code page. COVID-19 vaccines brands that can currently be recorded on the AIR:
On 1 November 2021, the TGA determined that Covaxin (manufactured by Bharat Biotech, India) and BBIBP-CorV (manufactured by Sinopharm, China) vaccines would be ‘recognised’ for the purpose of establishing a traveller’s vaccination status, along with the previously announced recognition of Coronavac (manufactured by Sinovac, China) and Covishield (manufactured by AstraZeneca, India).
Vaccines currently approved in Australia are:
AstraZeneca Vaxzevria
Pfizer/Biontech Comirnaty
Moderna Spikevax
Janssen-Cilag COVID Vaccine.
Vaccines recognised by TGA for travel into Australia:
Vaccine wastage refers to the loss of vaccine doses due to cold chain breaches, expired vials or other damage. The COVID-19 Vaccination Training gives details on how to dispose of vaccines:
Prior to disposal, the outer packaging (carton) should be defaced by striking through at least one panel of the carton with a sharpie or similar marker.
Any unused vaccine or waste material should be disposed of in accordance with local requirements in a clinical waste bin – vials must be disposed of in the provided sharps container to ensure they cannot be accessed.
wastage less than 5 vials should be reported in your Vaccine Stock Management Report; and
wastage of 5 vias and over should also be reported within the Wastage Report
wastage incidents (e.g. damaged vials or breach of cold chain requirements), of 5 vias and over must be reported immediately (within 2 hours of the incident occurring) by calling the VOC on 1800 318 208
GPs are now able to use the Specialist Assessment and Supervised Vaccination Clinics (SASVC) pathway to support their patients who have contraindications or precautions to vaccination or have experienced a serious Adverse Event Following an Immunisation (AEFI).
GPs and immunisation providers can email clinical questions to NSWISS, and NSWISS will provide advice to GPs who can then refer patients to an LHD in NSW that runs a Specialist Assessment and Supervised Vaccination Clinic (SASVC).
SASV clinics are now operational at Royal Prince Alfred, Liverpool, Campbelltown, Westmead Adults, John Hunter, Royal North Shore, Nepean and Wollongong Hospitals, with more being added.
Practices are encouraged to routinely review delegates in HPOS, including when staff leave an organisation. Visit the Services Australia website for instruction on how to edit and remove members delegations. All healthcare professionals with a HPOS account have access to My access history, which is an activity log showing a record of HPOS logins by users and their delegates for the previous 90 days. This is available via the main menu, My details, My access history:
The use of HPOS and associated programs is governed by laws and government policies, including the Australian Immunisation Register Act 2015, Privacy Act 1988 and HPOS Terms of Use.
Join the latest COVID-19 vaccine live stream update for GPs. The panel will provide latest key updates and answer participants’ questions live about the COVID-19 vaccine rollout. Get involved by submitting questions and comments!
Maroubra Medicare Urgent Care Clinic (UCC) is now open The Maroubra Medicare Urgent Care Clinic (UCC) is now open, seven days a week, from 8.00am to 8.00pm. It was officially launched by member for Kingsford Smith, the hon Matt Thistlethwaite MP (pictured at the launch with CESPHN CEO Nathalie Hansen…
Media Release: Central and Eastern Sydney PHN releases Healthy Ageing Strategy to empower older people In response to the increasing longevity and rapid growth of the older population the Central and Eastern Sydney Primary Health Network (CESPHN) is proud to release its new Healthy Ageing Strategy 2023-2028. This comprehensive strategy…
Immunisation Weekly Update: COVID-19 XBB.1.5 vaccine onboarding The Australian Government has accepted the latest advice from ATAGI on the use of the new COVID-19 XBB 1.5 vaccine as part of the National COVID-19 Vaccine Program. All sites currently participating in the COVID-19 Vaccination Program will be onboarded for the three…
Immunisation Weekly Update: Increase in COVID-19 infection cases ATAGI notes a recent increase in COVID-19 cases since November 2023 across Australia and encourages all eligible people who have not yet had their recommended 2023 COVID-19 vaccine dose/s to receive them as soon as possible. A first 2023 dose is recommended…
Immunisation Weekly Update: Vaccination coverage in RACF Australian Immunisation Register (AIR) data suggests that only 36% of people aged 70+ living in the central and eastern Sydney PHN region are immunised against Pneumococcal diseases. Immunisation providers are reminded to check AIR immunisation history statements of patients going into Residential Aged…
Immunisation Weekly Update: Introduction of Shingrix® to the NIP From 1 November 2023, the shingles vaccine Shingrix® will replace Zostavax® on the National Immunisation Program (NIP) schedule for the prevention of shingles and post-herpetic neuralgia. It will be available for eligible people most at risk of complications from shingles. A…
Continuing Professional Development (CPD) annual requirements Below is a snapshot of the continuing professional development (CPD) requirements for doctors, these include annual requirements of: completion of a Professional Development Plan 50 hours CPD each year, split across a range of activities: 25 hours – reviewing performance and measuring outcomes (with five hours minimum…
CESPHN’s Annual Report 2022-23 is now live Central and Eastern Sydney PHN has released its Annual Report 2022-23. The Annual Report is a summary of the key achievements and highlights for the PHN over the financial year. It is split into Improving Care Integration, Improving Practice and Commissioning Services to…